Juncture Wealth Strategies LLC boosted its holdings in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 197.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,174 shares of the biotechnology company’s stock after purchasing an additional 6,759 shares during the period. Axon Enterprise comprises 1.1% of Juncture Wealth Strategies LLC’s holdings, making the stock its 18th largest position. Juncture Wealth Strategies LLC’s holdings in Axon Enterprise were worth $4,299,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Keating Financial Advisory Services Inc. bought a new stake in shares of Axon Enterprise during the 2nd quarter worth $31,000. Washington Trust Advisors Inc. boosted its holdings in shares of Axon Enterprise by 1,300.0% in the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after buying an additional 65 shares during the last quarter. Delos Wealth Advisors LLC bought a new position in Axon Enterprise during the second quarter valued at about $45,000. Owl Creek Wealth Partners LLC grew its position in Axon Enterprise by 84.8% during the second quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 39 shares during the period. Finally, Global Assets Advisory LLC bought a new position in Axon Enterprise during the first quarter valued at about $70,000. Institutional investors own 79.08% of the company’s stock.
Analysts Set New Price Targets
Several analysts have commented on the stock. Piper Sandler lifted their price objective on shares of Axon Enterprise from $724.00 to $732.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Argus increased their target price on shares of Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. Barclays raised their price target on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $715.00 price objective on shares of Axon Enterprise in a research note on Thursday, August 6th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $721.57.
Insider Buying and Selling
In related news, CEO Patrick Smith sold 10,000 shares of the stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the sale, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the transaction, the insider owned 97,761 shares of the company’s stock, valued at approximately $61,266,818.70. This represents a 8.95% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 47,397 shares of company stock valued at $26,722,984. 4.20% of the stock is owned by company insiders.
Axon Enterprise Stock Performance
Axon Enterprise stock traded up $6.81 during mid-day trading on Tuesday, reaching $418.62. The company’s stock had a trading volume of 1,477,202 shares, compared to its average volume of 1,054,419. The firm’s fifty day moving average price is $527.78 and its two-hundred day moving average price is $478.49. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $764.02. The company has a market capitalization of $34.01 billion, a P/E ratio of 173.70, a PEG ratio of 7.78 and a beta of 1.44.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same quarter in the prior year, the business posted $2.12 earnings per share. The business’s quarterly revenue was up 35.3% on a year-over-year basis. Sell-side analysts predict that Axon Enterprise, Inc will post 2.12 EPS for the current fiscal year.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.
The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.
Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.
Recommended Stories
- Five stocks we like better than Axon Enterprise
- Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI
- Lamb Weston’s Turnaround Is Starting to Look Real
- These 3 Stocks Got the Most Love From Analysts in September
- Record French Debt Could Create Opportunities for U.S. Market Operators
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
